| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | high-affinity IgG receptor activity | 2.65e-06 | 2 | 33 | 2 | GO:0019771 | |
| GeneOntologyMolecularFunction | leukotriene receptor binding | 2.65e-06 | 2 | 33 | 2 | GO:0031774 | |
| GeneOntologyMolecularFunction | IgG receptor activity | 5.53e-05 | 7 | 33 | 2 | GO:0019770 | |
| GeneOntologyMolecularFunction | IgG binding | 1.44e-04 | 11 | 33 | 2 | GO:0019864 | |
| GeneOntologyMolecularFunction | immunoglobulin receptor activity | 2.38e-04 | 14 | 33 | 2 | GO:0019763 | |
| GeneOntologyMolecularFunction | immunoglobulin binding | 1.61e-03 | 36 | 33 | 2 | GO:0019865 | |
| GeneOntologyBiologicalProcess | type III hypersensitivity | 2.63e-05 | 5 | 34 | 2 | GO:0001802 | |
| GeneOntologyBiologicalProcess | regulation of type III hypersensitivity | 2.63e-05 | 5 | 34 | 2 | GO:0001803 | |
| GeneOntologyBiologicalProcess | positive regulation of type III hypersensitivity | 2.63e-05 | 5 | 34 | 2 | GO:0001805 | |
| GeneOntologyBiologicalProcess | determination of adult lifespan | 9.58e-05 | 54 | 34 | 3 | GO:0008340 | |
| GeneOntologyBiologicalProcess | positive regulation of type IIa hypersensitivity | 1.18e-04 | 10 | 34 | 2 | GO:0001798 | |
| GeneOntologyBiologicalProcess | positive regulation of type II hypersensitivity | 1.18e-04 | 10 | 34 | 2 | GO:0002894 | |
| GeneOntologyBiologicalProcess | regulation of type IIa hypersensitivity | 1.44e-04 | 11 | 34 | 2 | GO:0001796 | |
| GeneOntologyBiologicalProcess | regulation of type II hypersensitivity | 1.44e-04 | 11 | 34 | 2 | GO:0002892 | |
| GeneOntologyBiologicalProcess | antibody-dependent cellular cytotoxicity | 2.03e-04 | 13 | 34 | 2 | GO:0001788 | |
| GeneOntologyBiologicalProcess | type IIa hypersensitivity | 2.73e-04 | 15 | 34 | 2 | GO:0001794 | |
| GeneOntologyBiologicalProcess | positive regulation of hypersensitivity | 2.73e-04 | 15 | 34 | 2 | GO:0002885 | |
| GeneOntologyBiologicalProcess | type II hypersensitivity | 2.73e-04 | 15 | 34 | 2 | GO:0002445 | |
| GeneOntologyBiologicalProcess | positive regulation of acute inflammatory response to antigenic stimulus | 3.53e-04 | 17 | 34 | 2 | GO:0002866 | |
| GeneOntologyBiologicalProcess | positive regulation of phagocytosis, engulfment | 3.97e-04 | 18 | 34 | 2 | GO:0060100 | |
| GeneOntologyBiologicalProcess | positive regulation of membrane invagination | 3.97e-04 | 18 | 34 | 2 | GO:1905155 | |
| GeneOntologyBiologicalProcess | negative regulation of muscle tissue development | 3.97e-04 | 18 | 34 | 2 | GO:1901862 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous peptide antigen via MHC class I | 3.97e-04 | 18 | 34 | 2 | GO:0042590 | |
| GeneOntologyBiologicalProcess | regulation of hypersensitivity | 4.43e-04 | 19 | 34 | 2 | GO:0002883 | |
| GeneOntologyBiologicalProcess | maintenance of location | 4.47e-04 | 396 | 34 | 5 | GO:0051235 | |
| GeneOntologyBiologicalProcess | immunoglobulin mediated immune response | 5.82e-04 | 235 | 34 | 4 | GO:0016064 | |
| GeneOntologyBiologicalProcess | protein localization to cell periphery | 5.97e-04 | 422 | 34 | 5 | GO:1990778 | |
| GeneOntologyBiologicalProcess | positive regulation of inflammatory response to antigenic stimulus | 6.53e-04 | 23 | 34 | 2 | GO:0002863 | |
| GeneOntologyBiologicalProcess | B cell mediated immunity | 6.70e-04 | 244 | 34 | 4 | GO:0019724 | |
| GeneOntologyBiologicalProcess | blood vessel development | 6.80e-04 | 929 | 34 | 7 | GO:0001568 | |
| GeneOntologyBiologicalProcess | regulation of phagocytosis, engulfment | 7.12e-04 | 24 | 34 | 2 | GO:0060099 | |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion transmembrane transport | 7.62e-04 | 109 | 34 | 3 | GO:1904427 | |
| GeneOntologyBiologicalProcess | regulation of membrane invagination | 7.73e-04 | 25 | 34 | 2 | GO:1905153 | |
| GeneOntologyBiologicalProcess | hypersensitivity | 7.73e-04 | 25 | 34 | 2 | GO:0002524 | |
| GeneOntologyBiologicalProcess | maintenance of protein location | 8.25e-04 | 112 | 34 | 3 | GO:0045185 | |
| GeneOntologyBiologicalProcess | maintenance of location in cell | 8.38e-04 | 259 | 34 | 4 | GO:0051651 | |
| GeneOntologyBiologicalProcess | vasculature development | 8.73e-04 | 969 | 34 | 7 | GO:0001944 | |
| GeneOntologyBiologicalProcess | regulation of acute inflammatory response to antigenic stimulus | 9.02e-04 | 27 | 34 | 2 | GO:0002864 | |
| GeneOntologyBiologicalProcess | protein localization to membrane | 9.26e-04 | 705 | 34 | 6 | GO:0072657 | |
| GeneOntologyBiologicalProcess | vasculogenesis | 9.60e-04 | 118 | 34 | 3 | GO:0001570 | |
| Domain | Znf_CCCH | 1.73e-04 | 58 | 35 | 3 | IPR000571 | |
| Domain | ZF_C3H1 | 1.73e-04 | 58 | 35 | 3 | PS50103 | |
| Domain | MAM_1 | 4.03e-04 | 16 | 35 | 2 | PS00740 | |
| Domain | MAM | 4.56e-04 | 17 | 35 | 2 | SM00137 | |
| Domain | MAM | 5.12e-04 | 18 | 35 | 2 | PF00629 | |
| Domain | MAM_dom | 5.12e-04 | 18 | 35 | 2 | IPR000998 | |
| Domain | MAM_2 | 5.12e-04 | 18 | 35 | 2 | PS50060 | |
| Domain | EGF | 9.42e-04 | 235 | 35 | 4 | SM00181 | |
| Domain | EGF-like_dom | 1.17e-03 | 249 | 35 | 4 | IPR000742 | |
| Domain | zf-CCCH | 3.80e-03 | 49 | 35 | 2 | PF00642 | |
| Domain | USP_CS | 6.79e-03 | 66 | 35 | 2 | IPR018200 | |
| Domain | USP_1 | 7.61e-03 | 70 | 35 | 2 | PS00972 | |
| Domain | IG | 7.67e-03 | 421 | 35 | 4 | SM00409 | |
| Domain | Ig_sub | 7.67e-03 | 421 | 35 | 4 | IPR003599 | |
| Domain | UCH | 7.82e-03 | 71 | 35 | 2 | PF00443 | |
| Domain | USP_2 | 7.82e-03 | 71 | 35 | 2 | PS00973 | |
| Domain | USP_3 | 8.03e-03 | 72 | 35 | 2 | PS50235 | |
| Domain | USP_dom | 8.03e-03 | 72 | 35 | 2 | IPR028889 | |
| Domain | Peptidase_C19_UCH | 8.03e-03 | 72 | 35 | 2 | IPR001394 | |
| Domain | Ig_2 | 8.25e-03 | 73 | 35 | 2 | PF13895 | |
| Domain | EGF_3 | 9.57e-03 | 235 | 35 | 3 | PS50026 | |
| Domain | EGF_1 | 1.19e-02 | 255 | 35 | 3 | PS00022 | |
| Domain | EGF-like_CS | 1.27e-02 | 261 | 35 | 3 | IPR013032 | |
| Domain | IG_LIKE | 1.30e-02 | 491 | 35 | 4 | PS50835 | |
| Domain | EGF_2 | 1.32e-02 | 265 | 35 | 3 | PS01186 | |
| Domain | Ig-like_dom | 1.41e-02 | 503 | 35 | 4 | IPR007110 | |
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 28814603 | ||
| Pubmed | Features and protective efficacy of human mAbs targeting Mycobacterium tuberculosis arabinomannan. | 9.84e-07 | 2 | 35 | 2 | 37733444 | |
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 28289219 | ||
| Pubmed | Amelioration of Lupus Serum-Induced Skin Inflammation in CD64-Deficient Mice. | 9.84e-07 | 2 | 35 | 2 | 35273604 | |
| Pubmed | IgG3-mediated enhancement of the antibody response is normal in Fc gammaRI-deficient mice. | 9.84e-07 | 2 | 35 | 2 | 16305642 | |
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 9257847 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 21124939 | ||
| Pubmed | Macrophages eliminate circulating tumor cells after monoclonal antibody therapy. | 9.84e-07 | 2 | 35 | 2 | 24430180 | |
| Pubmed | Expression of modified FcγRI enables myeloid cells to elicit robust tumor-specific cytotoxicity. | 9.84e-07 | 2 | 35 | 2 | 38885133 | |
| Pubmed | Novel Fc gamma receptor I family gene products in human mononuclear cells. | 9.84e-07 | 2 | 35 | 2 | 1430234 | |
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 15835266 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 8663283 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 25231998 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 30190171 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 16750274 | ||
| Pubmed | Molecular cloning and expression of the mouse high affinity Fc receptor for IgG. | 9.84e-07 | 2 | 35 | 2 | 2136886 | |
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 1830050 | ||
| Pubmed | FcRγ deficiency improves survival in experimental sepsis by down-regulating TLR4 signaling pathway. | 9.84e-07 | 2 | 35 | 2 | 30552619 | |
| Pubmed | Sensory Neuron Expressed FcγRI Mediates Postinflammatory Arthritis Pain in Female Mice. | 9.84e-07 | 2 | 35 | 2 | 35833115 | |
| Pubmed | Differential gene expression modulated by the cytoplasmic domain of Fc gamma RIa (CD64) alpha-chain. | 9.84e-07 | 2 | 35 | 2 | 15528358 | |
| Pubmed | Functional characteristics of the high affinity IgG receptor, FcγRI. | 9.84e-07 | 2 | 35 | 2 | 21325219 | |
| Pubmed | Fc receptors and the common gamma-chain in experimental autoimmune encephalomyelitis. | 9.84e-07 | 2 | 35 | 2 | 14991835 | |
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 1402657 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 8611682 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 24021477 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 16409296 | ||
| Pubmed | Mouse FcgammaRI: identification and functional characterization of five new alleles. | 9.84e-07 | 2 | 35 | 2 | 10752630 | |
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 30744065 | ||
| Pubmed | Serum anti-Fcgamma receptor autoantibodies in patients with alopecia areata. | 9.84e-07 | 2 | 35 | 2 | 17124586 | |
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 31211699 | ||
| Pubmed | Linkage on chromosome 3 of autoimmune diabetes and defective Fc receptor for IgG in NOD mice. | 9.84e-07 | 2 | 35 | 2 | 8480181 | |
| Pubmed | Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies. | 9.84e-07 | 2 | 35 | 2 | 29576375 | |
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 18245810 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 16849450 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 8478020 | ||
| Pubmed | FcγR-binding affinity of monoclonal murine IgG1s carrying different N-linked Fc oligosaccharides. | 9.84e-07 | 2 | 35 | 2 | 31554601 | |
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 38524127 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 8077658 | ||
| Pubmed | The involvement of FcR mechanisms in antibody-mediated rejection. | 9.84e-07 | 2 | 35 | 2 | 18049118 | |
| Pubmed | Neonatal Fc receptor for IgG regulates mucosal immune responses to luminal bacteria. | 2.95e-06 | 3 | 35 | 2 | 16841095 | |
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 12427132 | ||
| Pubmed | MicroRNA-127 inhibits lung inflammation by targeting IgG Fcγ receptor I. | 2.95e-06 | 3 | 35 | 2 | 22287715 | |
| Pubmed | Tpl2 kinase regulates FcγR signaling and immune thrombocytopenia in mice. | 2.95e-06 | 3 | 35 | 2 | 23898046 | |
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 22003208 | ||
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 12594281 | ||
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 15880819 | ||
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 28924242 | ||
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 9892619 | ||
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 30636035 | ||
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 26056254 | ||
| Pubmed | The essential role of complement in antibody-mediated resistance to Salmonella. | 2.95e-06 | 3 | 35 | 2 | 30179254 | |
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 8697799 | ||
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 23728777 | ||
| Pubmed | FcγRI mediates serum amyloid P inhibition of fibrocyte differentiation. | 2.95e-06 | 3 | 35 | 2 | 22493081 | |
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 16543474 | ||
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 24161960 | ||
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 12707052 | ||
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 19657115 | ||
| Pubmed | Fc-optimized antibodies elicit CD8 immunity to viral respiratory infection. | 2.95e-06 | 3 | 35 | 2 | 33032297 | |
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 9763663 | ||
| Pubmed | C1q-Dependent Dendritic Cell Cross-Presentation of In Vivo-Formed Antigen-Antibody Complexes. | 2.95e-06 | 3 | 35 | 2 | 28432146 | |
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 30297432 | ||
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 12875993 | ||
| Pubmed | 3.72e-06 | 30 | 35 | 3 | 27729526 | ||
| Pubmed | 5.90e-06 | 4 | 35 | 2 | 9551950 | ||
| Pubmed | 5.90e-06 | 4 | 35 | 2 | 17182593 | ||
| Pubmed | 5.90e-06 | 4 | 35 | 2 | 16517729 | ||
| Pubmed | Unveiling skin macrophage dynamics explains both tattoo persistence and strenuous removal. | 5.90e-06 | 4 | 35 | 2 | 29511065 | |
| Pubmed | 5.90e-06 | 4 | 35 | 2 | 21169548 | ||
| Pubmed | Evidence for Cd101 but not Fcgr1 as candidate for type 1 diabetes locus, Idd10. | 5.90e-06 | 4 | 35 | 2 | 15850792 | |
| Pubmed | 5.90e-06 | 4 | 35 | 2 | 31562320 | ||
| Pubmed | Fc receptor regulation of protective immunity against Chlamydia trachomatis. | 5.90e-06 | 4 | 35 | 2 | 11872097 | |
| Pubmed | 5.90e-06 | 4 | 35 | 2 | 10760808 | ||
| Pubmed | 5.90e-06 | 4 | 35 | 2 | 9490697 | ||
| Pubmed | Glycoprotein VI-dependent and -independent pathways of thrombus formation in vivo. | 5.90e-06 | 4 | 35 | 2 | 16455953 | |
| Pubmed | 5.90e-06 | 4 | 35 | 2 | 1379234 | ||
| Pubmed | 5.90e-06 | 4 | 35 | 2 | 12517949 | ||
| Pubmed | 5.90e-06 | 4 | 35 | 2 | 16452176 | ||
| Pubmed | The mouse Fc receptor for IgG (Ly-17): molecular cloning and specificity. | 5.90e-06 | 4 | 35 | 2 | 2957319 | |
| Pubmed | 5.90e-06 | 4 | 35 | 2 | 28028748 | ||
| Pubmed | 5.90e-06 | 4 | 35 | 2 | 15485887 | ||
| Pubmed | Fc receptor-mediated antibody regulation of T cell immunity against intracellular pathogens. | 5.90e-06 | 4 | 35 | 2 | 12898452 | |
| Pubmed | 5.90e-06 | 4 | 35 | 2 | 10770797 | ||
| Pubmed | 5.90e-06 | 4 | 35 | 2 | 9171347 | ||
| Pubmed | Fcgamma receptor cross-linking stimulates cell proliferation of macrophages via the ERK pathway. | 5.90e-06 | 4 | 35 | 2 | 19996316 | |
| Pubmed | 5.90e-06 | 4 | 35 | 2 | 12705859 | ||
| Pubmed | 5.90e-06 | 4 | 35 | 2 | 15138262 | ||
| Pubmed | 5.90e-06 | 4 | 35 | 2 | 12528127 | ||
| Pubmed | Dynamic macrophage "probing" is required for the efficient capture of phagocytic targets. | 5.90e-06 | 4 | 35 | 2 | 21135140 | |
| Pubmed | Immune complex-loaded dendritic cells are superior to soluble immune complexes as antitumor vaccine. | 5.90e-06 | 4 | 35 | 2 | 16585547 | |
| Pubmed | 9.82e-06 | 5 | 35 | 2 | 17053192 | ||
| Pubmed | 9.82e-06 | 5 | 35 | 2 | 19050295 | ||
| Pubmed | Efficient IgG-mediated suppression of primary antibody responses in Fcgamma receptor-deficient mice. | 9.82e-06 | 5 | 35 | 2 | 10051626 | |
| Pubmed | C-reactive protein binding to murine leukocytes requires Fc gamma receptors. | 9.82e-06 | 5 | 35 | 2 | 10640769 | |
| Pubmed | 9.82e-06 | 5 | 35 | 2 | 19380812 | ||
| Pubmed | 9.82e-06 | 5 | 35 | 2 | 16520392 | ||
| Pubmed | Destructive arthritis in the absence of both FcgammaRI and FcgammaRIII. | 9.82e-06 | 5 | 35 | 2 | 18354234 | |
| Pubmed | Role of FcRs in animal model of autoimmune bullous pemphigoid. | 9.82e-06 | 5 | 35 | 2 | 16920981 | |
| Pubmed | Mouse model recapitulating human Fcγ receptor structural and functional diversity. | 9.82e-06 | 5 | 35 | 2 | 22474370 | |
| Pubmed | 9.82e-06 | 5 | 35 | 2 | 9143687 | ||
| Cytoband | 19p13 | 1.96e-04 | 27 | 35 | 2 | 19p13 | |
| Cytoband | 2p23.3 | 1.25e-03 | 68 | 35 | 2 | 2p23.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q24 | 4.26e-03 | 127 | 35 | 2 | chr2q24 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2p23 | 5.80e-03 | 149 | 35 | 2 | chr2p23 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q21 | 8.09e-03 | 177 | 35 | 2 | chr15q21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q21 | 1.01e-02 | 199 | 35 | 2 | chr9q21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrXp22 | 1.56e-02 | 250 | 35 | 2 | chrXp22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | 2.26e-02 | 797 | 35 | 3 | chr19p13 | |
| GeneFamily | Immunoglobulin like domain containing | 1.59e-03 | 193 | 22 | 3 | 594 | |
| GeneFamily | Ubiquitin specific peptidases | 2.09e-03 | 56 | 22 | 2 | 366 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.36e-07 | 186 | 35 | 5 | 5784d255e9ca449d375d81938d0fbbd8a7eb44f6 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.04e-06 | 152 | 35 | 4 | 621e9b33cd3bb1c7b7d0633069f286b203e3d9c0 | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-early_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-05 | 174 | 35 | 4 | 268be5e7d2a18b866770b7cdb966c3958c7e6534 | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-early_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-05 | 174 | 35 | 4 | 4cdf2eedc28d88d18241ee390092426fdf849e79 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-B_(Myofibroblast)|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.10e-05 | 177 | 35 | 4 | e55d21d4d61a069b9bbe0e7595fbfb7cfbacfd87 | |
| ToppCell | VE-plasma|VE / Condition, Cell_class and T cell subcluster | 1.10e-05 | 177 | 35 | 4 | 0c1cc0834de55717cb4f69d020339060ce2c9a03 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-B_(Myofibroblast)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.10e-05 | 177 | 35 | 4 | 43ba6f12c2fb32698a420bf799d46ac1b558f146 | |
| ToppCell | VE-plasma-|VE / Condition, Cell_class and T cell subcluster | 1.10e-05 | 177 | 35 | 4 | 3a3c94cf30012e2aa266bc4d7fe772e45fa90f6d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.15e-05 | 179 | 35 | 4 | 78fae47ec9bff4e0159a86a281e831d7f8ee925a | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.18e-05 | 180 | 35 | 4 | 01f2e5d96016823482f89ba503d007d4bd88eeac | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Endothelial-blood_vessel_EC-Mature_arterial_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.20e-05 | 181 | 35 | 4 | 0ba91575fe8851788cebc4cf5a6d76680bf586c5 | |
| ToppCell | Endothelial-E|World / shred on cell class and cell subclass (v4) | 1.28e-05 | 184 | 35 | 4 | b4c561924c508536fd2112e91e32176b95fdf63a | |
| ToppCell | (00)_Basal-(4)_1wkpi|(00)_Basal / shred by cell type and Timepoint | 1.31e-05 | 185 | 35 | 4 | bf82ba905e5eee1c39a2731702071d3de10a78b8 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.37e-05 | 187 | 35 | 4 | 3ae3b8de1a195d4d5057cf3c64fcdb5f48681ce5 | |
| ToppCell | (5)_Epi_basal|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 1.49e-05 | 191 | 35 | 4 | 6bda3d5a8a391d41bb4d65872492e6c094bcc4d4 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.49e-05 | 191 | 35 | 4 | b9ae5af426e7a1f2652a47700bb168371bd2dec6 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.52e-05 | 192 | 35 | 4 | fee99ca7e658963acf968aa724ef8c96cfc00a5d | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 1.55e-05 | 193 | 35 | 4 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | 343B-Endothelial_cells-Endothelial-B_(Artery)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.58e-05 | 194 | 35 | 4 | 582db7f7fa9aa08027ae18ed607945b5d1dc908a | |
| ToppCell | 343B-Endothelial_cells-Endothelial-B_(Artery)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.58e-05 | 194 | 35 | 4 | bda89111386398a072b70e8153b2a762298a047a | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.65e-05 | 196 | 35 | 4 | e7bfd4fb400ae0c473131d0fa306c26be08a6d03 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.65e-05 | 196 | 35 | 4 | 82fad623212d986a7fca3496faf3f8c8f5b83a11 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.65e-05 | 196 | 35 | 4 | 85e5046f774537684e1443c0fc147d562b7068d0 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Mesofibroblastic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.68e-05 | 197 | 35 | 4 | d7cef7881abd807a679432766ced609a6efd1067 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.68e-05 | 197 | 35 | 4 | 16758f181ef07c60aee63072e1da9572c5c85414 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.68e-05 | 197 | 35 | 4 | 44673c38384453207871d3fd8e8ba9093cc06bc5 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Mesofibroblastic-Mesothelia|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.68e-05 | 197 | 35 | 4 | 20a5958512bdb99daeb8f4d244df53e4f048f879 | |
| ToppCell | Fibroblasts-DKK3+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.71e-05 | 198 | 35 | 4 | 4f4632f26a2043c5e4ab89031b4229b5dca1bd48 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.71e-05 | 198 | 35 | 4 | f261a37dd07976548b897af86df1d1a0dc069889 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.71e-05 | 198 | 35 | 4 | 5e781583908c4ee107d986904a646a7c6b8e3591 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.71e-05 | 198 | 35 | 4 | 300d7cc56207d77168390fa1ffcbcf76767b1b80 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.71e-05 | 198 | 35 | 4 | 4961a3e9b953679648586afed04869ff36b81820 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.75e-05 | 199 | 35 | 4 | e1066e638af83ba5e89c7cabb8ad00b6bcdee5f4 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Fibroblastic-Fibro_peribronchial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.75e-05 | 199 | 35 | 4 | e9009eee7f77b9c9917f8e0e723001d9e76eb553 | |
| ToppCell | distal-1-mesenchymal-Myofibroblast|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.75e-05 | 199 | 35 | 4 | 58c36f5a30c6862b7f5587a0b9bc31da99e43dd5 | |
| ToppCell | Biopsy_Other_PF-Mesenchymal-Fibroblasts|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.78e-05 | 200 | 35 | 4 | 9996b6887cf2b1936e10a1aa396f09fd8da5f4c4 | |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX-Artery|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.78e-05 | 200 | 35 | 4 | 34b279804475ea58fbb052b96f44128c082627a9 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Artery|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.78e-05 | 200 | 35 | 4 | 8552cc7a439449b30b59760c3e8667217b9852b5 | |
| ToppCell | Tracheal|World / Cell types per location group and 10X technology with lineage, and cell group designations | 1.78e-05 | 200 | 35 | 4 | 682960e28542a3d6c119047cd0131941932cfdea | |
| ToppCell | Bronchial-NucSeq-Stromal-Chondrocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.78e-05 | 200 | 35 | 4 | b7b9441fa7ab0d43741a2ebd5ec1a48d537c6d47 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Artery-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.78e-05 | 200 | 35 | 4 | 45c08f1befe78553bbadcc2fcffb6138306638f3 | |
| ToppCell | Bronchial-NucSeq-Stromal-Chondrocytic-Chondrocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.78e-05 | 200 | 35 | 4 | 7c673ad0ea503ebd196579684d25d5f9e6a41030 | |
| ToppCell | Control-B_naive-4|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.03e-04 | 116 | 35 | 3 | 35d471c8dbf408d0be3837c428d9c2a73c805a6f | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Fam19a1_Tmem182|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.25e-04 | 124 | 35 | 3 | 690595d710b57b7cff8029a3bb06a8dd7e3c03c1 | |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.91e-04 | 143 | 35 | 3 | 28e936c298a45f88d14f0146caf3d5a22d483cd5 | |
| ToppCell | Club_cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 2.07e-04 | 147 | 35 | 3 | 5a824c89e4d045af465d7333275f8191fb29b041 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Ntn1_Npy2r|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.11e-04 | 148 | 35 | 3 | 5e738522d4ad35e08bc4ff8c41b7bea38ec6ef95 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Ntn1_Npy2r|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.29e-04 | 152 | 35 | 3 | 8ff5a178a8f3550d89a003c0858820aab3773386 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.42e-04 | 155 | 35 | 3 | 77fdae85d36efb776db977eb424b32487ef222e4 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_B-Pro-B|bone_marrow / Manually curated celltypes from each tissue | 2.47e-04 | 156 | 35 | 3 | b093dbba6662e4fffc8aa577587b77f64ac44b56 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.51e-04 | 157 | 35 | 3 | f147e24f2ece82e1c54750868954d09b3c461804 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.56e-04 | 158 | 35 | 3 | e5636c0b608d68bd426a2b446ac508e4512e86a4 | |
| ToppCell | droplet-Kidney-nan-3m-Myeloid-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.61e-04 | 159 | 35 | 3 | bea6e96ba40ebfc1e38687bfa1c61fe227c5a84d | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.71e-04 | 161 | 35 | 3 | 2d63b279d9a5132e1c09b03930bf9039036d24a2 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.71e-04 | 161 | 35 | 3 | 9f02b94e29e60d50e92eaa748ebf0c36d3671bb3 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-E|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.76e-04 | 162 | 35 | 3 | e17632778a57c71d6005d3abca3a0443a92040e7 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-E-|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.76e-04 | 162 | 35 | 3 | ac4a80fd72c9311ea2b3e574c6284bbce4f2756c | |
| ToppCell | TCGA-Colorectal-Solid_Tissue_Normal-Colon_normal_tissue-Colon_normal_tissue-6|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 2.76e-04 | 162 | 35 | 3 | 7f9385aa749bfb2fa9fee6939fe46d946bc21d31 | |
| ToppCell | normal-na-Lymphocytic_B-B_cell-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 2.76e-04 | 162 | 35 | 3 | ae292318d339305932457bb0e91430594f7a3dfa | |
| ToppCell | Club_cells-Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 2.86e-04 | 164 | 35 | 3 | 4e25e6362ef793b08de2f4d1dccb6b1fc9c072a5 | |
| ToppCell | 10x5'-blood-Lymphocytic_Invariant-Inducer-like-ILC3|blood / Manually curated celltypes from each tissue | 2.91e-04 | 165 | 35 | 3 | f012a27ece54c0f7b73a2f4f89c6ee8b865f8782 | |
| ToppCell | Influenza_Severe-B_memory|Influenza_Severe / Disease group and Cell class | 2.91e-04 | 165 | 35 | 3 | 51172acaeb667b34b8b8c7878d67cfa0c4a2dffc | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Lymphocytic|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.01e-04 | 167 | 35 | 3 | e1b1a952fce27ab9cf16919b290625ff4a75261e | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-Treg_cell_4|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 3.07e-04 | 168 | 35 | 3 | 63437b3c3a66f953eaed600965ab193f9cc49da2 | |
| ToppCell | COVID-19-kidney-PEC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.07e-04 | 168 | 35 | 3 | a086c306be430adf0632ba53e98cd8014d2de330 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c4-CD14-CD16|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.12e-04 | 169 | 35 | 3 | e3100eb587005e160bd0b7990fa57ec49765133d | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-8|TCGA-Liver / Sample_Type by Project: Shred V9 | 3.23e-04 | 171 | 35 | 3 | c4a919fe3d56ae6df2fcab6686abacc10befc053 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.23e-04 | 171 | 35 | 3 | fe0665c5ca01b0b2cc8f20d64587f0847c3d215c | |
| ToppCell | PND07-28-samps-Myeloid-Macrophage-CD163+_Macrophage|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 3.28e-04 | 172 | 35 | 3 | 9a659442dc41bd2a4361a7e38a7ee37a39781667 | |
| ToppCell | TCGA-Colorectal-Solid_Tissue_Normal-Colon_normal_tissue|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 3.28e-04 | 172 | 35 | 3 | 94842346c84542a5243bd765e49f4af8bc5182db | |
| ToppCell | TCGA-Colorectal-Solid_Tissue_Normal-Colon_normal_tissue-Colon_normal_tissue|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 3.28e-04 | 172 | 35 | 3 | 5d654dd030ed22a701e15c5f09002951d99a52e8 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.34e-04 | 173 | 35 | 3 | 1f16d47f5548e257e4b17f8070c5619780a9c5fd | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.34e-04 | 173 | 35 | 3 | 8888434641ea554a9b62c436e87920378eef29cd | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage-macrophage,_alveolar-Macro_c6-VCAN|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.40e-04 | 174 | 35 | 3 | eaaf17a06efc09ed4752b449827b1f0f424d3dad | |
| ToppCell | 10x5'-blood-Lymphocytic_Invariant-Inducer-like|blood / Manually curated celltypes from each tissue | 3.40e-04 | 174 | 35 | 3 | 51be6f29308c01593978cbee92114151a5916c9c | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.45e-04 | 175 | 35 | 3 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.45e-04 | 175 | 35 | 3 | 59249c9e83952d7277010e7be3c779e26399eb5d | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-stromal_related|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.45e-04 | 175 | 35 | 3 | 2fbffcb843f364645b99d1211698d96092abc5ef | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.45e-04 | 175 | 35 | 3 | b35cc1357495f2a03a6500f807c6e6f8c877734d | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-stromal_related-Germ|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.45e-04 | 175 | 35 | 3 | d0d5ae2a9357aa183ab720c891d86b80c9822930 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-early_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.51e-04 | 176 | 35 | 3 | 7292e014b8f697f0c2e9f47c48333de95cb44a69 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.51e-04 | 176 | 35 | 3 | 4ed73c73972334f6dc4229920205547823252fa0 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-early_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.51e-04 | 176 | 35 | 3 | 88ca2f83d8301633232735f39b0683efe49d0b86 | |
| ToppCell | wk_08-11-Mesenchymal-Chondrocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.51e-04 | 176 | 35 | 3 | 1af28b701c4598ce761f85adbd5d79e4918d265a | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-3_VIP_SSTR1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.57e-04 | 177 | 35 | 3 | fdab7b7ddfb06f913b8224c0c80574dc3cf4cbd4 | |
| ToppCell | RV-11._Adipocyte|RV / Chamber and Cluster_Paper | 3.63e-04 | 178 | 35 | 3 | 278bbea5cf8f0589f71675c7a3d00679391b5253 | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.63e-04 | 178 | 35 | 3 | 544379f5a6145429762258d426b876bb36c112f5 | |
| ToppCell | Adult-Epithelial-club_cell-D122|Adult / Lineage, Cell type, age group and donor | 3.63e-04 | 178 | 35 | 3 | 35a2e3ba98b6f857dbb79cf8ddb4846ddcda6c17 | |
| ToppCell | E16.5-samps-Endothelial-Immature_fetal_endothelial-Proliferative_Endothelial|E16.5-samps / Age Group, Lineage, Cell class and subclass | 3.69e-04 | 179 | 35 | 3 | d24513a404c9b1d37dd47aa1cdb5713b64b88f89 | |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial-endothelial_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.69e-04 | 179 | 35 | 3 | c7c74e26bbf86c5326ee38bac7de111d5414f46b | |
| ToppCell | Epithelial-basal_cell|World / Lineage, Cell type, age group and donor | 3.69e-04 | 179 | 35 | 3 | d9be6647ec7b22747dc00dce4ea307b6af412dfa | |
| ToppCell | 3'-Broncho-tracheal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_mucus_secreting_cell-SMG_mucous-SMG_mucous_L.0.6.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.75e-04 | 180 | 35 | 3 | 8af51245ac1269f318268f574cfaddb0b8c80a53 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.75e-04 | 180 | 35 | 3 | 1363b3254470f6ff98630d1df83a1bdbacc137e0 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-G|390C / Donor, Lineage, Cell class and subclass (all cells) | 3.75e-04 | 180 | 35 | 3 | 137fc14859c89e1ecd98bee388bb58c04b835847 | |
| ToppCell | Control-Epithelial-Goblet|Control / Disease state, Lineage and Cell class | 3.75e-04 | 180 | 35 | 3 | 5293d23b8b8ea587239ffde561b70bad01632521 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-G-|390C / Donor, Lineage, Cell class and subclass (all cells) | 3.75e-04 | 180 | 35 | 3 | cd6790de050151fedfa2c5ea6ad58b72665414b2 | |
| ToppCell | MS|World / Condition, Cell_class and T cell subcluster | 3.81e-04 | 181 | 35 | 3 | 99f054a586a95947528dc3fd8043c1bda5e74cc4 | |
| ToppCell | facs-Marrow-T_cells-18m-Hematologic-MPP_Fraction_B|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.81e-04 | 181 | 35 | 3 | 064057ab36c6d92c36572b73142b42d201709d7b | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.81e-04 | 181 | 35 | 3 | 9c157de9d3403e092c907599f2a2c16db5b21131 | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.81e-04 | 181 | 35 | 3 | 3fe648db1cb8326066d8bde3ca1287c5c9af19bd | |
| Drug | 1ct8 | 6.45e-06 | 173 | 35 | 5 | CID000444888 | |
| Disease | retinal degeneration (biomarker_via_orthology) | 4.10e-06 | 28 | 33 | 3 | DOID:8466 (biomarker_via_orthology) | |
| Disease | Alzheimer disease, polygenic risk score | 4.55e-04 | 586 | 33 | 5 | EFO_0030082, MONDO_0004975 | |
| Disease | chloride measurement | 4.83e-04 | 29 | 33 | 2 | EFO_0009284 | |
| Disease | hyperuricemia | 6.27e-04 | 33 | 33 | 2 | EFO_0009104 | |
| Disease | transient cerebral ischemia (biomarker_via_orthology) | 7.17e-04 | 157 | 33 | 3 | DOID:224 (biomarker_via_orthology) | |
| Disease | psoriasis (is_marker_for) | 1.11e-03 | 44 | 33 | 2 | DOID:8893 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FHSTSKGYMGECGYR | 336 | Q8TD30 | |
| HASKRGCFMYGNSFS | 436 | Q8NDL9 | |
| YFFTYHVLMRGGDGT | 171 | Q5VWW1 | |
| YAHGTKLSYTCEGGF | 891 | P08603 | |
| FHGSYGTFYMCETTL | 286 | Q5VUD6 | |
| MSGGKYVDSEGHLYT | 1 | Q03135 | |
| MYITCAEYTHFYGGK | 11 | Q13356 | |
| VCGKHATMFGQGSYF | 551 | Q7Z3E1 | |
| SHYEQVMTAFGGKGY | 516 | Q9UJ83 | |
| GVSGKHCLTFFYHMY | 576 | Q7Z304 | |
| YHCSGMGKHRYTSAG | 166 | Q92637 | |
| MSYFLSYCKAHGGAL | 1 | Q8N239 | |
| GTCTSCAMGYYRFDH | 1051 | Q92824 | |
| LEGSYMCSCHKGYTR | 1056 | Q14766 | |
| SYMRGGYFSSSHEGF | 311 | P41161 | |
| RLSFYSGHSSFGMYC | 161 | O43688 | |
| GSSSVRPGLYHYCFM | 1346 | P42858 | |
| AGKYYCHRGNLTMSF | 256 | P15391 | |
| YTGMHKGCAFLTYCA | 81 | Q8N6W0 | |
| YHCSGMGKHRYTSAG | 166 | P12314 | |
| GGYHVSAKCFGYMTQ | 811 | Q8WUI4 | |
| VSMGYHKKTYGGYQG | 96 | P10915 | |
| GHTMCTYDFYEGQGR | 211 | O95045 | |
| AGNSGETCYSKYGAM | 266 | Q9NXH9 | |
| TEGYYTSMHFDCGLK | 781 | Q6T4R5 | |
| GFHGYKCMRQGSFSL | 186 | Q6UW56 | |
| HASGNGTTKDYCMLY | 31 | Q8TCT8 | |
| GKFYHCINYTTGEMF | 1361 | Q99250 | |
| AICYYHCSFRMTGEG | 111 | Q3MJ13 | |
| GDHGYYSMLGDFSKL | 541 | Q5HYM0 | |
| SSGKYTFAAHMDGTY | 76 | Q15363 | |
| SMLRGRGGCYKHTFY | 386 | Q9NV66 | |
| GTTMGGHYTAYCRSP | 551 | O75604 | |
| AFKRTCGLSYYMGQH | 31 | Q8NFA0 | |
| TFDGRHFGFMGKCTY | 1166 | Q9Y493 |